Lv4
500 积分 2021-07-14 加入
First-in-Man CD123-Specific Chimeric Antigen Receptor-Modified T Cells for the Treatment of Refractory Acute Myeloid Leukemia
17天前
已关闭
Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia
19天前
已完结
Characteristics of anti-CLL1 based CAR-T therapy for children with relapsed or refractory acute myeloid leukemia: the multi-center efficacy and safety interim analysis
19天前
已完结
Cancer-Related Distress and Unmet Needs Among Acute Myeloid Leukemia Survivors
19天前
已关闭
Research Highlights
19天前
已完结
Combination regimens containing daratumumab for initial diagnosed acquired thrombotic thrombocytopenic purpura
2个月前
已完结
Strategies for the Prophylaxis of Invasive Fungal Diseases in Acute Myeloid Leukemia Patients Undergoing Bcl-2 Inhibitor Venetoclax Treatment
2个月前
已完结
Clinical characteristics and survival outcomes of patients with Primary Central Nervous System Lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
5个月前
已完结
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry
6个月前
已完结
Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis
6个月前
已完结
皖公网安备34019202002308
